Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript

EXAS earnings call for the period ending March 31, 2023.

Related Keywords

Japan ,United States ,Jordan ,America ,American ,Americans ,Catherine Schulte ,Brandon Couillard Jefferies ,Vijay Kumar ,Andrew Brackmann William Blair ,Matt Sykes Goldman Sachs ,Canaccord Genuity ,Dan Brennan Cowen ,Jeff Elliott ,Jack Meehan ,Dan Brennan ,Andrew Brackmann ,Matt Sykes ,William Blair ,Alex Nowak ,Vijay Kumar Evercore ,Kyle Mikson Canaccord Genuity ,Megan Jones ,Patrick Donnelly ,Dan Arias ,Puneet Souda ,Brandon Couillard ,Kyle Mikson ,Kevin Conroy ,Everett Cunningham ,Goldman Sachs ,Supreme Court ,American Association Of Cancer Research Conference ,Jack Meehan Nephron Research Analyst ,Dan Arias Stifel Financial Corp ,Craig Hallum Capital Group ,Alex Nowak Craig Hallum Capital Group Analyst ,Nephron Research ,Company Analyst ,Sciences Corporation ,Exact Sciences ,Exact Science ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Chief Operating ,Precision Oncology ,American Association ,Cancer Research Conference ,Derik De Bruin ,Investor Day ,Craig Hallum Capital ,Hallum Capital Group ,Analyst Day ,Chief Commercial ,Stifel Financial ,